Monovalent norovirus Vaccine (Vaxart)

N/A

Report date: 2022/09/23 20:01:17

Base Information

Drug NameMonovalent norovirus Vaccine (Vaxart)

Drug Alias NameNorovirus GI.1 vaccineH1N1 (high dose) Oral Vaccine TabletH1N1 (low dose) Oral Vaccine TabletMonovalent GI.1 norovirus vaccineVXA-G1.1-NN +[6]

ClassificationVaccines > Biological material > Viral vaccineVaccines > Application > Prophylactic vaccineVaccines > Vaccine type > Univalent vaccine

Mechanisms of ActionImmunostimulantsToll like receptor 3 agonists

TargetsToll like receptor 3

Therapy Area/IndicationsNorovirus Infections

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited StatesSouth Africa

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

Originator CompaniesVaxart Inc

China Registration ClassN/A

Develop Information

Active CompaniesVaxart Inc

Inactive CompaniesN/A

Active IndicationsNorovirus Infections

Inactive IndicationsN/A

Other Information

ATC CodeN/A